Debara Reese

FDA investigator

Appears on 6 documents from 2015 to 2023, mostly at sites in Indiana. Most often cites process validation (21 CFR 820.75(a)).

6
Documents on file
4.8
Observations per 483
2015
First seen
2023
Most recent

What they cite most

From 28 observations

Activity by year

2015: 1, 2016: 1, 2017: 1, 2019: 1, 2020: 1, 2023: 1

Where

Indiana 6

Is Debara Reese coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Eli Lilly and CompanyJun 16, 2023 · . Indianapolis, Indiana
483 Cook IncFeb 7, 2020 · Bloomington, Indiana
483 Analytical Control Systems, IncDec 19, 2019 · Fishers, Indiana
483 Cook IncJan 26, 2017 · Bloomington, Indiana
483 Symmetry Medical USA IncJun 15, 2016 · Warsaw, Indiana
483 Medivative Technologies, LLCJun 4, 2015 · Indianapolis, Indiana

About this profile

What does Debara Reese inspect?

Debara Reese appears on 6 documents on file covering 5 sites, mostly in Indiana.

What do they cite most often?

21 CFR 820.75(a) (process validation), followed by 21 CFR 820.100(a) and 21 CFR 820.30(d).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Debara Reese is dated Jun 16, 2023.

FDA Investigator Debara Reese: 483s & Inspections · FDA Intel